DENVER, COLORADO--(MARKET WIRE)--Sep 26, 2006 -- Medical International Technology Inc. (OTC BB:MDLH.OB - News) (http://www.mitcanada.ca http://www.mitinvest.ca), is pleased to announce the sale of 10 units of the AGRO-JET MIT II P for the Poultry farm and 6 units of the Agro-Jet MIT X for the Pork farm in Malaysia. MIT is also pleased to announce the sale of 2 units of the AGRO-JET MIT III and 2 units of the Agro-Jet MIT VI for the Pork farm in Mexico.

At the present time, the world's Animal industry (Poultry, Pork, Cattle etc.) commonly uses a needle/syringe to vaccinate. The current method for vaccination requires that the needle be changed after a few hundred birds in Poultry; between 20 and 35 in Pork and few Cattle's have been injected. This method poses a major problem as cross contamination may occur and more importantly, increases the risk of infecting the person vaccinating, with an accidental needlesticks and Sharps Injuries.

"Medical International Technology Inc. is pleased to be able to continue providing a safer, low pressure needle-free injection solution to the Global Animal industry," With the use of "MIT" AGRO-JET, we can safely vaccinate all Animals and help prevent the spread of deadly disease to Animals and Humans.

Karim Menassa, President

On Behalf of the Board of Directors

About Medical International Technology, Inc. MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individual and mass vaccinations

The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing a technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. Medical International Technology Inc. takes no obligation to update or correct forward-looking statements.